Treatment Action Group

Statement from TAG, Global TB CAB on H56:IC31 Phase IIb trial results

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Read More →

Report: TB Research Funding Trends 2005-2022

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Read More →

TAG's 2023 Pipeline Report: TB Diagnostics

Treatment Action Group launches the 2023 Tuberculosis Diagnostics Pipeline Report.

Read More →

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Read More →

Activism delivers unprecedented victories in TB testing and treatment access

Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

Read More →

TAG's 2023 Pipeline Report: TB vaccines

Treatment Action Group launches the first TB chapter of its 2023 Pipeline Report.

Read More →

TAG condemns GSK actions surrounding potential TB vaccine revealed by bombshell ProPublica report

The report portrays how GSK’s financial interests have – and will likely continue to – set back progress against the world’s deadliest infectious disease lays bare just how egregiously large pharmaceutical companies bilk the global public, and makes an urgent case for government and philanthropic funders to take action and demand better.

Read More →

Nearly all countries “far off track” of meeting TB research targets despite publicly reaffirming commitments at UN

A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.

Read More →

At this week’s UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign calls on political leaders to take urgent action for equitable access to shorter, safer TB regimens

Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.

Read More →

Information note: New fair share funding targets for TB research 0.1% -> 0.15%

Treatment Action Group releases an updated Information note providing details on the new 0.15% fair share funding targets for TB research.

Read More →

Page 1 of 22 · Total posts: 10

1 2 Last→